chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Systemic: Dizziness / Lightheadness-Mild, Systemic: Nausea-Mild, Systemic: Vomiting-Mild, Additional Details: she was nervous, after shot felt nausea, lightheaded, and vomited up some water.
This spontaneous report as received from a nurse practitioner regarding a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not reported. On 27-OCT-2009, patient received improperly stored VARIVAX dose 2, from batch/lot # 664468/0684Y (expiry date, dose units, route and anatomical location were not specified). Concomitant medication were not reported. No adverse effects were reported. The reporter stated that inconsistencies in storage temperature were identified on extensive review and records. The reporter stated that vaccine was not thawed. The nurse practitioner reported that there was insufficient data to provide 100 percent assurance on vaccine stability. This is one the several reports received from the same reporter. Additional information has been requested.
I began to feel an icy/cold sensation along top of arms, in my back, and in my thighs. I then began to feel sweaty and lightheaded. I alerted the nurse and asked for Benadryl because I have had a similar reaction to Cephalosporins and required a trip to the ED. I took one Benadryl and then went to lie down. I lied down until 02:10 pm. I could still feel the icy sensation, but no longer felt sweaty or lightheaded.
Patient received 5-11 year old Pfizer bivalent booster immunization instead of age appropriate Pfizer booster (12+)
Raised bumps; Rash; Diarrhea; Stomach hurt; Felt lousy; Injection site has itched; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE MASS (Raised bumps), DIARRHOEA (Diarrhea), ABDOMINAL PAIN UPPER (Stomach hurt), FEELING ABNORMAL (Felt lousy) and VACCINATION SITE PRURITUS (Injection site has itched) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included LOSARTAN, PRAVASTATIN, MONTELUKAST and ESOMEPRAZOLE SODIUM (NEXIUM [ESOMEPRAZOLE SODIUM]) for an unknown indication.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced DIARRHOEA (Diarrhea), ABDOMINAL PAIN UPPER (Stomach hurt), FEELING ABNORMAL (Felt lousy) and VACCINATION SITE PRURITUS (Injection site has itched). On 25-Mar-2021, the patient experienced VACCINATION SITE MASS (Raised bumps) and RASH (Rash). On 14-Mar-2021, DIARRHOEA (Diarrhea), ABDOMINAL PAIN UPPER (Stomach hurt) and FEELING ABNORMAL (Felt lousy) had resolved. At the time of the report, VACCINATION SITE MASS (Raised bumps), VACCINATION SITE PRURITUS (Injection site has itched) and RASH (Rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.
I contracted COVID-19 on 5/15/2022 with symptoms of runny nose, congestion, chest heaviness, cough, low-grade fever, difficulty breathing, shortness of breath, elevated heartrate, headache, fatigue, and mild myalgia. I went to the ER on 5/17/2022 for an elevated heart rate, difficulty breathing, and oxygen level dropped to 93. I took Tylenol and Advil for my symptoms, as well as zinc 30mg 3 times daily, quercetin 250mg 2 times daily, vitamin D3 1000 iu once daily, vitamin C 1000mg once daily, Mucinex 2 times daily, Zyrtec, and Flonase Sensimist 2 times daily. My symptoms are resolving, but I am still fatigued and short of breath.
Patient developed a 5 X 3cm area surrounding site of injection on right thigh. The area was red, warm to the touch, and slightly swollen and raised.
On 1/11 in the evening, I noticed a red bump on my arm where I had received the vaccine. It was hard, but small. Then I woke up this morning (1/12), and my arm had a red rash, about 2-3 cm each way from where the vaccine was administered. It is itchy and warm. I have no other symptoms.
Fatigue - 1 day Sore Arm - 3 days Swollen Lymph Nodes in Neck (vaccine side) - began 6 days after vaccine and on-going. Swollen lymph node is at base of neck where neck meets collar bone and is protruding from neck and visible in mirror
Uncontrollably shaking, Congestion, shivering, took Tylenol.
The patient became nauseated within 1 hour of the vaccination,  then had an emesis and was nauseated for the remainder of the day. Also reported chills, and severe headache.
Developed redness & rash on back. Lasted up to 7 days. Patient used anti-histamine medicine to relieve rash.
Patient in vaccine clinic to receive 1st dose Pfizer Covid-19 vaccine, patient with her mother, stated she sometimes gets lightheaded with vaccines but has never fainted.  After paperwork completed staff suggested that a quiet room and ability to lay down with vaccine would be best , staff, patient and mother walked to EMS room half way to EMS room tp get vaccine patient fainted and staff able to catch her with chair. Transported to EMS room per w/c.  Able to lie down on cot and given ice packs and water when feeling better received Vaccine dose of Pfizer in L deltoid no issues.  Remained in EMS room until 5:15 then ambulated w/o assist with mother.
I noticed that something was up with my cycle around the middle of June. I track my hormones every day for fertility hormones. My cycle increased by seven days in June and it has stayed elevated since. My cycle is 27-28 days usually and now it's up to 35 days. In July, my luteinizing hormones stopped spiking; and my estrogen levels for the past few months have been really high. Estrogen level testing to be done soon. I just finished my period yesterday - I'll get a baseline estrogen test and then another test in a few days after that. It's a walk-in appt and I'll go in today or tomorrow morning. I test my urine samples almost every day for estrogen level and luteinizing hormone level increases. I had a doctor's visit about this a couple of weeks ago. He wants to do these tests first.
inadvertently administered an expired Kinrix; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 4-year-old male patient who received DTPa-IPV (Kinrix) (batch number H9FM5, expiry date 07-MAY-2023) for prophylaxis.   On 10-JUL-2023, the patient received Kinrix (right deltoid). On 10-JUL-2023, an unknown time after receiving Kinrix, the patient experienced expired vaccine used (Verbatim: inadvertently administered an expired Kinrix). The outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 11-JUL-2023 The reporter inquired if any information available and how to proceed. The reporter reported that they inadvertently administered an expired Kinrix in the right deltoid. The reporter did not consent to follow-up from safety. The patient received expired Kinrix, which led to expired vaccine used.
Pt called 7/13/16, returned call 7/14/16. Pt complains of tingling in hands, arms, fee, legs and face. Pt states began 7/9/16. Pt received vaccine 6/27/16. Advised Pt to notify his m.d. Pt states will go to clinic after work - LPN
This spontaneous case reported by an other healthcare professional, describes the occurrence of off-label use (missed scheduled second dose/45 days since first one) and product dose omission issue (missed second dose due to it raining badly outside) in a female patient, of an unknown age, who received mRNA-1273 (batch# 012A21A) for COVID-19 immunization. No medical history reported. On Mar 17, 2021, patient received the first dose of mRNA-1273, (intramuscular); 1 dosage form. On May 1, 2021, patient experienced product dose omission issue (missed second dose due to it raining badly outside). On an unknown date, patient experienced off-label use (missed scheduled second dose/45 days since first one). On May 1, 2021, product dose omission issue (missed second dose due to it raining badly outside) resolved. At the time of the report, off-label use (missed scheduled second dose/45 days since first one) resolved. The action taken with mRNA-1273, intramuscular: unknown. The reporter did not provide any causality assessments, concomitant medications or treatment information.
TD given 9-14-09; patient experienced erythema, at site.  Pain, fever 9-15-09 - reported 9-16-09.  Examined by Dr. - no treatment indicated other than supportive care.
Large local swelling at arm site of IN  & DTaP admin. Blotchy rash on body and hives over entire body, cough, SOB, went to ER, Benadryl IV, Home, Albuterol NMTs
I received sore throat; high temperature; congestion and body aches for 5 days.  I took Molnupiravir and I felt better.
Not so sore arm; headache; continuous bowel movements; Vomiting; severe indigestion; This spontaneous case was reported by a consumer and describes the occurrence of DYSPEPSIA (severe indigestion), PAIN IN EXTREMITY (Not so sore arm), HEADACHE (headache), FREQUENT BOWEL MOVEMENTS (continuous bowel movements) and VOMITING (Vomiting) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On 07-Mar-2021, the patient experienced DYSPEPSIA (severe indigestion), HEADACHE (headache), FREQUENT BOWEL MOVEMENTS (continuous bowel movements) and VOMITING (Vomiting). On an unknown date, the patient experienced PAIN IN EXTREMITY (Not so sore arm). On 08-Mar-2021, DYSPEPSIA (severe indigestion), FREQUENT BOWEL MOVEMENTS (continuous bowel movements) and VOMITING (Vomiting) had resolved. At the time of the report, PAIN IN EXTREMITY (Not so sore arm) and HEADACHE (headache) outcome was unknown.            No Concomitant Medications were provided. No treatment medications were provided.   This case was linked to MOD-2021-037723 (Patient Link).
10/28/20 Left shoulder and arm have been sore. The spot where my flu shot was given has continued to be extremely tender and sore. It is also VERY painful to raise my arm to the side even a small amount. I can raise it forward without difficulty. At times during the day and especially at night pain will shoot down my arm into my fingers. I'm trying not to use my shoulder/arm and am taking ibuprofen. Order PT for ROM/Pain
This is in follow-up to report (s) previously submitted on 6/24/2008. Information has been received from a physician concerning an 87-year-old female with reactions to all other medications the physician prescribed (specifics were not known; "can not tolerate any medication that had been prescribed")and a history of artiral fibrillation who on 06-NOV-2007 was vaccinated subcutaneously in left arm with her first dose of ZOSTAVAX (Oka/Merck) (Lot# 0966). On an unspecified date the patient experienced hot flashes and upset stomach. On 11-NOV-2007, the patient experienced blurred vision, dizziness, skin blotchs, skin itches and dry skin. At the time of the report the patient's status was unknown. The patient sought unspecified medical attention. A product quality complaint was not involved. Additional information is not expected.
Information has been received from a physician who in 1990 was vaccinated with varicella vaccine through a "study for VARIVAX." She reported that she was seropositive several times over the past 10 years, but this year's titer came back negative. Additional info has been requested.
I had soreness to injection site and nausea, but the nausea passed quickly. On Jan 1st I was tested for COVID and received positive results on Jan 2.
Fever; Chills; This case was reported by a consumer via interactive digital media and described the occurrence of fever in a female patient who received Herpes zoster (Shingrix) for prophylaxis.  On 10th November 2021, the patient received the 1st dose of Shingrix. On 11th November 2021, 1 days after receiving Shingrix, the patient experienced fever and chills. On an unknown date, the outcome of the fever and chills were unknown.   It was unknown if the reporter considered the fever and chills to be related to Shingrix.  Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient got 1st shot the day before the reporting day and had fever and chills on the day of reporting, was this normal. No contact details were available.
Arm sore, bad headache, lethargic, temp increased to 101.6.  No medical treatment
Information has been received from a RN concerning a 6 yr old male who on 02Oct00 was vaccinated with a dose of varicella virus vaccine live (lot622850/0537E). Subsequently, on 04Jan06 the pt experienced mild varicella. Unspecified medical attention was sought. The RN noted that the pt experienced approx 10 varicella lesions. No outcome was reported. No product quality complaint was involved. Additional information has been requested.
I just had booster meaning third dose for the Pfizer vaccine; Lymph nodes inflammation under your armpit and chest they are swollen; Lymph nodes inflammation under your armpit and chest they are swollen; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 2021 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for COVID-19 Immunization; Bnt162b2 (DOSE 2, SINGLE), for COVID-19 Immunization. The following information was reported: IMMUNISATION (non-serious) with onset 2021, outcome "unknown", described as "I just had booster meaning third dose for the Pfizer vaccine"; LYMPHADENITIS (non-serious), LYMPHADENOPATHY (non-serious) all with onset 2021, outcome "unknown" and all described as "Lymph nodes inflammation under your armpit and chest they are swollen".  Additional information: It was reported that the patient had a concern about that the patient just had booster meaning third dose for the Pfizer vaccine, patient wanted to see how normal or not normal was to have lymph nodes inflammation under the armpit and chest, they are swollen.  The lot number for bnt162b2 was not provided and will be requested during follow up.
while @ office has red rash around both inj site;redness less, sent home;30min later projectile vomiting;jerking&fast breathing;pt listless&having gasping breathing;consistent w/hypotonic&hyporesponsive rxn;responded to IV&O2;next day nl;
6cm x 6cm reddened area over rt deltoid no fever no drainage, warm to touch;
Fever for 1 week, aches since injection, fatigue, flu-like symptoms,  horrible night sweats,
Woke in the morning with headache, myalgia, nausea, fatigue, chills. Went back to bed slept for 3 hours. Took ibuprofen 600mg Q 8 hours for 2 days.
This spontaneous report has been received from a nurse, regarding on a patient of unspecified age and gender. There was no information provided about the patient's concurrent conditions, concomitant therapies, historical drugs, drug reactions or allergies, or pertinent medical history. On 10-NOV-2020, the patient was vaccinated with RECOMBIVAX HB as prophylaxis. The expiration date of the vaccine was reported as 06-NOV-2020 (expired product administered) (strength, dosage, route of administration, anatomical site of vaccination, vaccination scheme frequency, and lot number were not reported). Follow-up information has been received from a nurse on 16-NOV-2020. The patient's name and the patient's physician's name was provided. A valid lot number for RECOMBIVAX HB was provided as R004185 with expiration dated given and upon internal validation confirmed as 06-NOV-2020. It was noted that the product had no prior temperature excursions. No product quality complaint. This case was previously considered to be non-valid but upon receipt of follow-up information that included patient identifiers it was updated to be valid.
Headache, Myalgia, Arthralgia, chills, muscle aches, injections sie was sore more than last time Narrative:
Lightheaded, dizziness. Weakness on the side of the injection. No energy and shortness of breath with activity ongoing. Patient normally very active and has not chronic conditions
Fever; Joint pain; Nausea; Severe headache; Swollen lymph nodes under left arm; Injection site pain; Muscle pain; Chills; This is a spontaneous report from a contactable consumer, the patient. A 71-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 29Apr2021 (at the age of 71-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 from 28Jan2021 to 14Feb2021 with the same symptoms as the events experienced after the vaccination, high blood pressure and mild pollen allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included bupropion (MANUFACTURER UNKNOWN), losartan potassium (LOSARTIN) and hydrochlorothiazide (MANUFACTURER UNKNOWN), all taken for an unspecified indication from an unknown date and unknown if ongoing. The patient previously received morphine (MANUFACTURER UNKNOWN) and codeine (MANUFACTURER UNKNOWN) and experienced drug allergy. On 30Apr2021 at 15:30, the patient experienced fever, joint pain, nausea, severe headache, swollen lymph nodes under left arm, injection site pain, muscle pain and chills. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, joint pain, nausea, severe headache, swollen lymph nodes under left arm, injection site pain, muscle pain and chills was resolved on an unknown date in 2021.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
low grade fever; fatigue; This spontaneous case was reported by an other health care professional and describes the occurrence of PYREXIA (low grade fever) and FATIGUE (fatigue) in a 4-month-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 3004956 and 3003657) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (low grade fever) and FATIGUE (fatigue). At the time of the report, PYREXIA (low grade fever) and FATIGUE (fatigue) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported. Treatment medications were not reported.
I had very mild symptoms except for fatigue. I did not have any fever. The first night I had a mild headache then congestion and postnasal drip. I tested positive on February 05, 2023, and was prescribed PAXLOVID on February 06, 2023. She said it was up to me to take the medication. I started to take the PAXLOVID, and it did not help. I gave me a horrible metallic taste in my mouth, but I had less fatigue. I tested positive for quite some time. I was down for the count for a month as I continued to test positive for a month. I was very isolated as people that knew me did not want to be around. At this time, I have completely recovered. The fatigue was a long-lasting symptom. It varies the way the doctors treat symptoms. I did not like that my doctor left it up to me to take the medication.
Pt. was fully vaccinated with Pfizer COVID vaccine 1/13/21 and 2/3/21.  Pt. reports COVID symptom onset of severe headache, fever, chills, body aches, cough, loss of taste, loss of smell, diarrhea, and congestion starting 7/11/21. Pt. received PCR COVID  test at clinic on 7/12/21.
Narrative:  Pt received the first COVID-19 pfizer vaccine 3/5/2021. He experienced a rash with this first dose. After receiving the second vaccine, the rash became more prominent and worse x 10 days. The rash progressed from the lower extremities to the rest of the body with significant pruritus, abdominal discomfort, N/V, and diarrhea 4-5x daily. He received dexamethasone, diphenhydramine, and normal saline as stated above. He was discharged same day
This case was reported by a pharmacy via a pharmacy claims management company and described the occurrence of adverse reaction in a female subject of unspecified age who was vaccinated with FLULAVAL TETRA (GlaxoSmithKline). On 7 January 2014 the subject received a dose of FLULAVAL TETRA (unknown details). At an unspecified time after vaccination with FLULAVAL TETRA, the subject experienced adverse reaction. At the time of reporting the outcome of the event was unspecified.
Autoimmune inflammatory polyneuropathy, Lupus. Muscle/joint pain, chronic fatigue, muscle twitching. neurological problems (forgetfulness, confusion, dizziness), ears ringing, digestive problems, malaise etc.